Synektik S.A.

CEBioForum 2026: A Premier Platform for Life Science Innovation and Collaboration

CEBioForum 2026, a leading international biotechnology conference, will take place on April 22–23, 2026, in Warsaw, Poland. For over 20 years, this event has served as a hub for connecting the life science communities of Central and Eastern Europe with the United States. The forum will bring together key stakeholders, including biotechnology and pharmaceutical leaders, medtech representatives, investors, scientists, and business support institutions, to discuss innovation commercialization, project financing, strategic partnerships, and the future of the sector, particularly the rapidly growing #polishbiotech.

The event offers numerous business opportunities, including:

• CEBioForum Awards: Recognizing the most innovative projects and companies in the region, enhancing their credibility and international visibility.
• Biotech Pitch Session: A platform for presenting projects to investors, venture capital funds, and industry partners.
• B2B Matchmaking App: Facilitating one-on-one meetings and efficient agenda planning to maximize networking value.
• Expert Panels and Keynote Speeches: Covering regulatory, investment, and technological trends in pharma, medtech, biotech, clinical trials, and data analysis.
• Access to Decision-Makers: A unique opportunity to meet key representatives of the Polish and regional life science ecosystem.

CEBioForum is organized by BioForum, an association of nearly 50 life science companies, which fosters collaboration between science and business, initiates acceleration projects, and promotes international partnerships. The event is a flagship initiative aimed at advancing the biotechnology sector in Poland and beyond.

Learn more about CEBioForum 2026

Relevance to Synektik S.A.: As a leader in medtech and a key player in the Polish life sciences sector, Synektik S.A. stands to benefit from the networking, partnership, and innovation opportunities offered by CEBioForum 2026, aligning with its focus on advanced medical technologies and strategic collaborations.

Synektik S.A. Secures Major Contract for Robotic Surgery System Delivery to Gdańsk University Clinical Center

Synektik S.A., a leading Polish medical technology company, has signed significant agreements with the University Clinical Center in Gdańsk for the delivery, installation, and commissioning of the fifth-generation da Vinci robotic surgery system. The contracts also include staff training, warranty-period service support, and the supply of consumables over a 48-month period. The total net value of the agreements amounts to PLN 21,201,352.31, funded by the National Recovery and Resilience Plan.

The project, awarded through an open public tender, is set for completion by May 30, 2026, with a 48-month warranty period starting from the final acceptance protocol. The agreements are considered crucial by Synektik's management, as their value exceeds 5% of the company’s equity, as reported in its latest financial statement. Revenue from this project is expected to positively impact Synektik’s financial results for fiscal years 2025-2027.

Relevance: This development aligns with Synektik S.A.'s business profile as a key distributor of advanced medical technologies, including robotic surgery systems, and underscores its leadership in delivering cutting-edge healthcare solutions in Poland.

Poland Considers Adopting Canadian Strategy to Address Men's Health Disparities

Poland is exploring the adaptation of Canada's "Men and Boys’ Health Strategy" to address significant health disparities between men and women. The Canadian initiative, launched in February, focuses on mental health, combating harmful social stereotypes, and improving early detection and prevention of common health issues, including cancer. Polish lawmakers, led by MP Marcin Józefaciuk, have highlighted the urgent need for a similar systemic approach, citing alarming statistics such as high suicide rates among men and inadequate access to preventive healthcare services.

Healthcare professionals in Poland have pointed out gaps in the system, such as limited diagnostic tools available to general practitioners and insufficient early screening for young males. Experts also emphasized the importance of educating men about self-examinations and addressing mental health challenges, particularly in rural areas where health risks are more pronounced. The National Health Fund (NFZ) has initiated campaigns to raise awareness, including outreach during sports events and partnerships with rural organizations. A preliminary draft of Poland's men's health strategy, tailored to local needs, is expected in May.

Additionally, workplace safety disparities were highlighted, with men accounting for 96% of fatal workplace accidents in 2024. Experts called for stronger public campaigns to promote health awareness and mental well-being, alongside free psychological support for men facing challenges such as divorce-related conflicts.

Relevance to Synektik S.A.: The focus on early cancer detection and preventive healthcare aligns with Synektik S.A.'s expertise in advanced medical technologies, including diagnostic imaging systems and radioisotopes for PET scans, which are critical for early diagnosis and treatment planning.

e-DiLO Implementation Delayed Until 2029, Aiming to Revolutionize Oncology Care

The long-awaited implementation of the electronic Diagnostic and Treatment Card for Oncology (e-DiLO) has been postponed to 2029, despite earlier promises of its rollout in 2025. The e-DiLO system, designed to streamline the diagnostic and therapeutic pathways for oncology patients, remains hindered by legislative delays, including the need for amendments to the National Oncology Network (KSO) Act. The system aims to replace the current paper-based DiLO cards, offering centralized access to patient data, diagnostic plans, treatment schedules, and integration with histopathology systems. This digital transformation is expected to enhance data sharing across medical facilities and improve patient care coordination.

In 2025, over 440,000 DiLO cards were issued, reflecting a steady increase in usage compared to previous years. However, the current paper-based system remains tied to specific medical facilities, creating inefficiencies for patients who switch hospitals or experience disease recurrence. The Ministry of Health has acknowledged the potential of e-DiLO to accelerate diagnostics and specialist consultations but emphasized that its integration with the national e-registration system will take several more years to materialize. For now, patients are advised to continue using the paper-based system for registration and referrals.

Experts, including Prof. Piotr Rutkowski and Prof. Jacek Jassem, have highlighted the transformative potential of e-DiLO in oncology care, emphasizing its ability to provide real-time updates on patient health and ensure continuity of care across facilities. However, the lack of legislative foresight in the original KSO Act has significantly delayed its implementation, leaving patients and healthcare providers to navigate the limitations of the current system.

Relevance to Synektik S.A.: The e-DiLO system aligns with Synektik S.A.'s focus on advanced IT solutions for healthcare, such as its PACS imaging systems and Zbadani.pl platform, showcasing the company's potential role in supporting the digital transformation of oncology care in Poland.

Synektik S.A. Announces Strategic Division of Assets into SYN2BIO S.A.

On March 18, 2026, Synektik S.A., a leading Polish medical technology company, will hold an Extraordinary General Meeting to discuss the division of the company’s assets. The proposed plan involves transferring a portion of Synektik’s assets to a newly established entity, SYN2BIO S.A. This strategic move aims to streamline operations and enhance the company’s focus on its core business areas, including the production of radiopharmaceuticals, distribution of advanced medical equipment, and development of healthcare IT solutions.

Synektik S.A. is renowned for its exclusive distribution of the da Vinci robotic surgery systems, production of PET radiopharmaceuticals, and innovative medical software solutions. The creation of SYN2BIO S.A. is expected to further strengthen the company’s position in the medical technology sector by enabling more specialized operations and fostering growth in targeted areas.

The decision to restructure reflects Synektik’s commitment to maintaining its leadership in the Polish healthcare market and adapting to evolving industry demands.

Relevance: This development aligns with Synektik S.A.’s business model of optimizing its operations across medical technology, radiopharmaceuticals, and IT solutions, ensuring sustained growth and innovation in its core sectors.

Key Events on the NewConnect Market Calendar for March 2026

The NewConnect market has announced a series of extraordinary general meetings scheduled for March 2026, involving several companies. These meetings will address critical corporate matters such as changes in supervisory boards, capital increases, and statutory amendments. Notable events include:

• March 18: FIGENE continues its extraordinary general meeting from February 16.
• March 19: GKSKAT, NOVINA, and UNIFIED will hold meetings to discuss changes in supervisory boards, share issuance, and remuneration policies.
• March 20: DEMGAMES plans to discuss a merger with Quest Craft SA, capital increases, and statutory changes, while AQUAPOZ will address supervisory board appointments.
• March 23: SWMANSION will hold a meeting to appoint new supervisory board members.

These developments reflect ongoing corporate governance adjustments and strategic decisions across the NewConnect market.

Relevance to Synektik S.A.: Monitoring corporate activities on the NewConnect market is crucial for Synektik S.A., as it operates in a competitive and dynamic environment where strategic decisions, such as capital increases or governance changes, can influence market trends and opportunities.

Key Economic Events Scheduled for March 18-24, 2026

The upcoming week is set to feature several significant economic and business events in Poland and beyond, with a focus on energy security, financial performance, and market challenges. Highlights include the PowerConnect Energy Summit 2026, a two-day forum starting on March 18, addressing energy transformation in the Baltic region and the development of domestic supply chains. The event will bring together government officials, energy company executives, and technology leaders.

Additionally, multiple companies will host financial results conferences, including CD Projekt on March 19, Żabka and Sanok Rubber Company on March 20, and Torpol on March 23. These sessions will provide insights into their 2025 performance and strategic plans for 2026. Other notable events include the NWAI press conference on March 18, focusing on operational and financial summaries, and the GUS conference on March 24, discussing the role of statistics in business decision-making.

These events reflect the dynamic economic landscape and the growing emphasis on innovation, sustainability, and financial transparency across industries.

Relevance to Synektik S.A.: The focus on technological innovation and strategic planning aligns with Synektik S.A.'s role as a leader in advanced medical technologies and IT solutions, emphasizing its position in a competitive and evolving market.

Challenges in Polish Healthcare System Reform Highlighted During Health Challenges Congress

Experts at the Health Challenges Congress (HCC) debated the ongoing challenges in reforming Poland's hospital system, expressing concerns over the lack of a clear and actionable plan to address patient needs. Waldemar Malinowski, President of the National Association of County Hospital Employers, criticized the absence of a comprehensive reform strategy and called for guaranteed funding for newly passed legislation. Bernadeta Skóbel from the Association of Polish Counties highlighted the uncertainty surrounding hospital restructuring due to unclear financial frameworks and changing reimbursement policies.

Filip Nowak, President of the National Health Fund (NFZ), emphasized the need for hospitals to base restructuring plans on demographic analyses and financial sustainability, while also addressing the issue of degressive payments for services exceeding contractual limits. Renata Wachowicz, Director of UCK SUM in Katowice, pointed out the financial strain caused by reduced reimbursement rates for over-limit procedures, such as vitrectomy. Meanwhile, Barbara Więckowska from the Ministry of Health stressed the need to adapt hospital infrastructure to modern treatment methods, such as day surgeries enabled by technological advancements.

The Ministry of Health announced plans to create a roadmap for hospital service provision, with a national transformation plan expected by the end of 2025. The recently signed legislation aims to rationalize and increase the flexibility of hospital services, encouraging the consolidation of acute care services and the transition to planned or one-day treatments where feasible. Financial incentives are also proposed to support these transformations.

Relevance to Synektik S.A.: The article underscores the growing importance of advanced medical technologies and IT solutions in modernizing healthcare systems, aligning with Synektik S.A.'s expertise in providing cutting-edge medical equipment, robotic surgical systems, and IT platforms for healthcare optimization.

Poland to Revamp Drug Policy with Focus on Domestic Production and Technological Advancements

Poland is set to introduce a new "State Drug Policy for 2026–2030," aiming for a comprehensive overhaul of the pharmaceutical sector. The strategy, announced by Deputy Health Minister Katarzyna Kacperczyk during the Health Challenges Congress, will emphasize a holistic approach to the sector, including reforms to the reimbursement law and the role of the Agency for Health Technology Assessment and Tariff System (AOTMiT). The government plans to allocate 31 billion PLN for drug reimbursement, while also redefining institutional roles and improving funding mechanisms.

A key focus of the policy is strengthening Poland's drug security by boosting domestic production. Industry leaders, including Barbara Misiewicz-Jagielak of Polpharma and Ewa Królikowska of Teva Pharmaceuticals Polska, highlighted the importance of local manufacturing to enhance resilience. However, they acknowledged the long-term nature of such investments, which require 15–20 years to materialize. Additionally, the strategy will prioritize the integration of advanced technologies, such as artificial intelligence, to accelerate drug research and support reimbursement decisions.

Dr. Anna Kowalczuk, the new president of the Medical Research Agency, advocated for simplified drug administration schemes and underscored the transformative potential of AI in the pharmaceutical industry. The overarching goal of the policy is to position Poland as a reliable partner for pharmaceutical companies while ensuring sustainable and efficient healthcare solutions for its citizens.

Relevance to Synektik S.A.: The emphasis on domestic production, advanced medical technologies, and AI-driven healthcare aligns with Synektik S.A.'s expertise in medical technology, IT solutions, and radioisotope production, presenting potential opportunities for collaboration and growth in the evolving Polish healthcare landscape.

Healthcare Industry Experts Question the Impact of Conferences and Panels

Dr. Anna Gołębicka, a business strategist and member of the National Health Fund Council, has raised critical questions about the effectiveness of the numerous healthcare conferences and panels held in recent years. In a recent discussion, she likened the healthcare sector to a hierarchical and complex "court of Louis XIV," where discussions often fail to translate into actionable changes. Dr. Gołębicka highlighted the prevalence of repetitive narratives from panelists and the growing fatigue among participants, as attendance at such events appears to be declining. Despite this, she acknowledged the importance of these gatherings for networking and staying informed about rapid changes in healthcare policies and market dynamics. She emphasized the unique challenges of the healthcare sector, including its complexity, hierarchical structure, and constant evolution of regulations and financial constraints.

Relevance to Synektik S.A.: As a leading provider of advanced medical technologies and IT solutions, Synektik S.A. operates in the highly dynamic healthcare sector. Staying informed about industry trends and regulatory changes discussed in such forums is crucial for maintaining its competitive edge and adapting to market needs.